Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics

/PRNewswire/ -- Epitopea, a transatlantic cancer immunotherapeutics company and global leader in exploiting a new class of untapped tumour-specific antigens...

Related Keywords

Montreal ,Quebec ,Canada ,Cambridge ,Cambridgeshire ,United Kingdom ,Canadian ,Laurence Rulleau ,Pierre Thibault ,Claude Perreault ,Jon Moore ,Linkedin ,Advent Life Sciences ,Harrington Discovery Institute University Health Holdings ,Partner At Advent Life Sciences ,Institute For Research ,Scius Communications ,Harrington Discovery Institute ,Canadian Centre Of Excellence ,Life Sciences ,Novel Cryptigen ,Tumour Specific ,Cambridge Innovation Capital ,Novateur Ventures ,Harrington Discovery ,University Health ,Canadian Centre ,Operating Partner ,Innovation Capital ,University Health Holdings ,